Inventor

Nicolas Desroy

Inventor
Massy, FR

Overview

20→
Patents
2015–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes28%
C07CAcyclic or carbocyclic compounds9%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
11,072,611Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders202110,988,454Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202110,981,890Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202110,844,042Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,844,041Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,829,473Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,647,717N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use202010,526,329Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders202010,428,017Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use201910,399,940Substituted pyrrolidines and methods of use201910,259,810N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use201910,130,622Compounds for treatment of cystic fibrosis201810,125,132Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders20189,981,910Substituted pyrrolidines and methods of use20189,890,158'N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use'20189,796,711'Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use'20179,796,719'Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders'20179,670,204'Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders'20179,249,141'Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders'20168,993,590'Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders'2015

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2015–2021Patents assigned to GALAPAGOS NV (20)· patent assignee history
2015–2021Based in Romainville, FR· patent location history
2017–2018Patents assigned to ABBVIE S Á R L (2)· patent assignee history
2017Patents assigned to ABBVIE S ÀR L (1)· patent assignee history
2017–2021Based in Massy, FR· patent location history
2018–2020Patents assigned to ABBVIE SARL (7)· patent assignee history
2020–2021Patents assigned to ABBVIE OVERSEAS SARL (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GALAPAGOS NV202015–2021
ABBVIE SARL72018–2020
ABBVIE OVERSEAS SARL52020–2021
ABBVIE S Á R L22017–2018
ABBVIE S ÀR L12017
Locations
LocationPatentsSpan
Massy, FR122017–2021
Romainville, FR82015–2021